MedPath

The role of plasma protein High Sensitive C-Reactive Protein in judging the amount of disease control in 5 to 12 year old children with asthma

Not Applicable
Conditions
Health Condition 1: J459- Other and unspecified asthma
Registration Number
CTRI/2021/03/032297
Lead Sponsor
Dr Niveditha T
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Asthmatic children of the age group 5-12 years attending the Paediatric Medical and Pulmonology OPD and admitted in the Medical and Pulmonology wards

Exclusion Criteria

Children with

-acute exacerbation of asthma

-active respiratory tract infection or any other infection within the past month

--systemic inflammatory diseases (such as collagen vascular diseases)

-chronic underlying disorders (such as cardiac, pulmonary and renal diseases)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To measure the levels of serum High Sensitive C-Reactive Protein in each groupTimepoint: Serum High Sensitive C-Reactive protein values are measured at one single point
Secondary Outcome Measures
NameTimeMethod
To compare the trend of serum hsCRP levels with the level of control of AsthmaTimepoint: The level of control of Asthma symptoms over the past month
© Copyright 2025. All Rights Reserved by MedPath